News & Alerts

Zevra Therapeutics Makes Strategic Leap into Rare Disease Market with Acer Therapeutics Acquisition

Zevra Therapeutics, a forward-looking pharmaceutical company, has taken an impressive stride toward establishing itself as a prominent player in the…

Read More »

Johnson & Johnson Slashes Price of TB Drug in Low-Income Countries to Expand Access

Seven weeks after announcing its decision to allow generic competition for the drug-resistant tuberculosis (TB) treatment Sirturo (bedaquiline) in low-…

Read More »

New Study Suggests Postnatal Antidepressant Use Benefits Child’s Development

In a promising revelation for new mothers grappling with postpartum depression, a recent study indicates that the use of selective…

Read More »

Newly Approved Narcan Overdose Formulation Set to Be Available Next Week at $44.99

According to reports, Narcan, a vital medication designed to reverse opioid overdoses, is set to become readily accessible on drugstore…

Read More »

The Hidden Price Of RSV Vaccine

According to an article published on August 25th in The New York Times, certain health insurance providers are not covering…

Read More »

Physician Fined and License Restricted for Improper Ivermectin Prescriptions and COVID-19 Misinformation

The Washington Medical Commission has taken disciplinary action against Dr. Richard Wilkinson, a physician who had been prescribing ivermectin to…

Read More »

GSK’s Malaria Vaccine Combined with Drugs Shows Over 90% Reduction in Cases

The final results of a groundbreaking study that evaluated the effectiveness of GSK’s Mosquirix malaria vaccine in combination with antimalarial…

Read More »

New Guidelines Suggest Safer Alternatives to Opioids for Kids’ Dental Pain

New guidelines suggest that children experiencing short-term dental pain from tooth extractions or toothaches should avoid being prescribed opioids. Instead,…

Read More »

Promising Trial Results: Wegovy Shows Potential in Alleviating Heart Failure Symptoms

Wegovy (semaglutide), a groundbreaking weight-loss drug, has been in the spotlight for its transformative impact on obesity and diabetes treatment.…

Read More »

CVS Health Ventures into Biosimilars Market with Cordavis: Disrupting Drug Costs and Accessibility

CVS Health has taken a decisive step in the realm of US biosimilars by introducing Cordavis, a novel business unit…

Read More »